Sage Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Sage Therapeutics Inc
TickerSAGE
CIK #0001597553
CUSIP78667J108
SectorLife Sciences - Pharmaceutical Preparations
Address215 First Street, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2025
[0001597553] 10-K
[0001597553] 10-Q
[0001597553] 3
[0001597553] 4
[0001597553] 5
[0001597553] 8-K
[0001597553] D
[0001597553] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BB Biotech AG Sage Therapeutics Inc [2023-02-17] 5.2
BlackRock Inc Sage Therapeutics Inc [2023-02-03] 8.3
BB Biotech AG Sage Therapeutics Inc [2021-08-11] 5.0
Wellington Management Group LLP Sage Therapeutics Inc [2021-02-04] 8.23
Biogen Inc Sage Therapeutics Inc [2021-01-11] 10.7
Capital International Investors Sage Therapeutics Inc [2020-02-14] 7.9
Visium Asset Management LP Sage Therapeutics Inc [2016-02-10] 5.9
Third Rock Ventures II LP Sage Therapeutics Inc [2015-02-13] 45.3
Arch Venture Fund VII LP Sage Therapeutics Inc [2015-02-11] 16.5
FMR LLC Sage Therapeutics Inc [2014-08-11] 0.0
Form 3/4/5 Filer 2011 - 2025
Sage Therapeutics, Inc.
Barrett Elizabeth
Iguchi KIMI
Federer Jessica
Cook Anne Marie
Gault Laura
Robichaud Albert
Greene Barry E
Benecchi Christopher
Jonas Jeffrey M
Golumbeski George
Paul Steven M
Starr Kevin P
Frates James M
Cola Michael F
Germano Geno J
Kanes Stephen
Cloonan Michael
Biogen MA Inc.
Biogen Inc
Nayak Asha
Anderson Thomas
Tepper Robert I
Third Rock Ventures GP II, L.P.
TRV GP II LLC
Levin Mark J
Third Rock Ventures II, L.P.
Pien Howard H
Nelsen Robert
ARCH Venture Partners VII, LLC
ARCH Venture Fund VII, L.P.
Crandell Keith
ARCH Venture Partners VII, L.P.
Bybee Clinton
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2023-03-31] DFND 7,081,381.0 7,083,533.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 5,714,423.0
BlackRock Inc. [2023-03-31] SOLE 4,813,662.0 4,929,567.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 4,882,871.0
Bellevue Group AG [2023-03-31] DFND 3,090,000.0 3,090,000.0
State Street Corp [2023-03-31] DFND 2,615,119.0 2,734,373.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 365,588.0 1,877,992.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 1,469,209.0 1,525,756.0
Marshall Wace LLP [2023-03-31] OTR 0.0 1,411,929.0
JPMorgan Chase & Co [2023-03-31] DFND 1,160,139.0 1,375,172.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 1,124,818.0
Boxer Capital, LLC [2023-03-31] OTR 1,094,000.0 1,094,000.0
Geode Capital Management LLC [2023-03-31] DFND 1,040,245.0 1,040,245.0
Goldman Sachs Group Inc [2023-03-31] DFND 902,917.0 946,138.0
Palo Alto Investors LP [2023-03-31] SOLE 859,517.0 859,517.0
Deutsche Bank AG [2023-03-31] DFND 718,166.0 777,413.0
Artal Group S.A. [2023-03-31] DFND 750,000.0 750,000.0
Manufacturers Life Insurance Company the [2023-03-31] DFND 624,671.0 624,671.0
Northern Trust Corp [2023-03-31] DFND 30,866.0 593,773.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 412,335.0 448,235.0
Susquehanna International Group LLP [2023-03-31] DFND 140,849.0 444,549.0
Fisher Asset Management LLC [2023-03-31] DFND 143,408.0 421,323.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 418,746.0
Finepoint Capital LP [2023-03-31] SOLE 388,865.0 388,865.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 385,417.0 385,417.0
Morgan Stanley [2023-03-31] DFND 260,622.0 372,652.0
Millennium Management LLC [2023-03-31] SOLE 366,663.0 366,663.0
Franklin Resources Inc [2023-03-31] DFND 300,274.0 301,723.0
Bank of America Corp /DE/ [2023-03-31] DFND 8,238.0 284,001.0
Bank of New York Mellon Corp [2023-03-31] DFND 211,575.0 248,632.0
Prev | Page 4 | Next
Terms | Privacy | Guide
tony@aum13f.com